This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Norman M. Kaplan, MD; Ray W. Gifford, Jr, MD

JAMA. 1996;275(20):1577-1580.

Abstract
Hypertension is one of the most common conditions treated by the clinician, yet accurate diagnosis and selection of the appropriate treatment can be challenging and recommendations regarding antihypertensive medications continue to evolve. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure recommends diet and exercise for the initial treatment of mild hypertension, followed by a diuretic or β-blocker if necessary, unless contraindicated. This recommendation is based on outcome studies using these drugs that demonstrate reductions in major diseases that treatment of hypertension is intended to prevent: stroke and cardiovascular morbidity and mortality. Other antihypertensive drugs, while not tested in large trials evaluating outcomes, have unique advantages for certain patients. Consideration of the patient's medical conditions and needs, including the cost of medication, is essential to ensuring optimal treatment of hypertension.

(JAMA. 1996;275:1577-1580)

Author Affiliations
From the Department of Internal Medicine and the Hypertension Division, University of Texas Southwestern Medical Center, Dallas (Dr Kaplan); and the Department of Nephrology, Internal Medicine, and Hypertension, Cleveland (Ohio) Clinic Foundation (Dr Gifford).

Footnotes
Corresponding author: Norman M. Kaplan, MD, Hypertension Division, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235-8899.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antihypertensive Drug Therapy in Saskatchewan: Patterns of Use and Determinants in Hypertension
Bourgault et al.
Arch Intern Med 2001;161:1873-1879.
ABSTRACT | FULL TEXT  

Should New Drugs Be Used Without Outcome Data?: Implications of ALLHAT and ELITE II
Kaplan
Arch Intern Med 2001;161:511-512.
FULL TEXT  

Occurrence and Progression of Dementia in a Community Population Aged 75 Years and Older: Relationship of Antihypertensive Medication Use
Guo et al.
Arch Neurol 1999;56:991-996.
ABSTRACT | FULL TEXT  

Diuretics and {beta}-Blockers Do Not Have Adverse Effects at 1 Year on Plasma Lipid and Lipoprotein Profiles in Men With Hypertension
Lakshman et al.
Arch Intern Med 1999;159:551-558.
ABSTRACT | FULL TEXT  

Why Are Physicians Not Prescribing Diuretics More Frequently in the Management of Hypertension?
Moser
JAMA 1998;279:1813-1816.
ABSTRACT | FULL TEXT  

Trends in Antihypertensive Drug Use in the United States: Do the JNC V Recommendations Affect Prescribing?
Siegel and Lopez
JAMA 1997;278:1745-1748.
ABSTRACT  

Health Outcomes Associated With Antihypertensive Therapies Used as First-Line Agents: A Systematic Review and Meta-analysis
Psaty et al.
JAMA 1997;277:739-745.
ABSTRACT  

Improving Care of Patients With Hypertension
Black
JAMA 1996;276:1036-1037.
ABSTRACT  

Choice of Antihypertensive Therapy During Pregnancy
Casele and Laifer
JAMA 1996;276:780-780.
ABSTRACT  

High Blood Pressure: Some Answers, New Questions, Continuing Challenges
Lenfant
JAMA 1996;275:1604-1606.
ABSTRACT